Vaxart to Participate at the Jefferies Global Healthcare Conference on June 5, 2025

Vaxart to Participate at the Jefferies Global Healthcare Conference on June 5, 2025 GlobeNewswire May 29, 2025 SOUTH SAN FRANCISCO, Calif., May 29, 2025 (GLOBE NEWSWIRE) — Vaxart, Inc. (NASDAQ: VXRT), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, today announced that members of the […]

NextCure and LigaChemBio to Present Trial in Progress Poster for LNCB74, a B7-H4 Targeted Antibody-Drug Conjugate, as Monotherapy in Participants with Advanced Solid Tumors at ASCO 2025

NextCure and LigaChemBio to Present Trial in Progress Poster for LNCB74, a B7-H4 Targeted Antibody-Drug Conjugate, as Monotherapy in Participants with Advanced Solid Tumors at ASCO 2025 GlobeNewswire May 29, 2025 LNCB74 is in a Phase 1, open-label, first-in-human study that will include dose escalation, safety, and biomarker backfills and randomized dose expansion/optimization The study

Ambarella, Inc. Announces First Quarter Fiscal Year 2026 Financial Results

Ambarella, Inc. Announces First Quarter Fiscal Year 2026 Financial Results GlobeNewswire May 29, 2025 SANTA CLARA, Calif., May 29, 2025 (GLOBE NEWSWIRE) — Ambarella, Inc. (NASDAQ: AMBA), an edge AI semiconductor company, today announced first quarter fiscal 2026 financial results for the period ended April 30, 2025. Revenue for the first quarter of fiscal 2026

Amneal to Participate at Upcoming Investor Conferences in June

Amneal to Participate at Upcoming Investor Conferences in June GlobeNewswire May 29, 2025 BRIDGEWATER, N.J., May 29, 2025 (GLOBE NEWSWIRE) — Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) will participate in two upcoming investor conferences: Jefferies Global Healthcare Conference on June 5, 2025, with company presentation at 9:20 AM ET, and Goldman Sachs Global Healthcare Conference on

Best Free Online Psychics Report Released by Manifest Kira LTD

New York City, NY, May 29, 2025 (GLOBE NEWSWIRE) — Manifest Kira LTD, a spiritual and psychic research company, announced the publication of its 2025 research report examining the best free online psychics offering reading services available through phone or live video calls. The study analyzed 12 different free online psychic service providers and identified

Best Free Online Psychics Report Released by Manifest Kira LTD

Best Free Online Psychics Report Released by Manifest Kira LTD Report on the Best Free Online Psychics with Free Trials in 2025 GlobeNewswire May 29, 2025 New York City, NY, May 29, 2025 (GLOBE NEWSWIRE) — Manifest Kira LTD, a spiritual and psychic research company, announced the publication of its 2025 research report examining the

ScanTech AI to Attend 10th Annual Smart Airport Conference & Exposition

(NasdaqGM:STAI), Atlanta, GA, May 29, 2025 (GLOBE NEWSWIRE) — ScanTech AI Systems Inc. (the “Company” or “ScanTech AI”) (Nasdaq: STAI), a leading innovator in advanced security screening technologies, today announced its scheduled participation in the 10th Annual Smart Airport Conference & Exposition, taking place July 15-17, 2025, in Atlanta, GA. The Company will showcase its

ScanTech AI to Attend 10th Annual Smart Airport Conference & Exposition

ScanTech AI to Attend 10th Annual Smart Airport Conference & Exposition Company to Highlight AI-Driven Security and Operational Technologies for Smart Airport Infrastructure GlobeNewswire May 29, 2025 Atlanta, GA, May 29, 2025 (GLOBE NEWSWIRE) — ScanTech AI Systems Inc. (the “Company” or “ScanTech AI”) (Nasdaq: STAI), a leading innovator in advanced security screening technologies, today

Kevin Ting Issues Open Letter to Paragon Technologies Shareholders

Expresses Deep Concern Regarding the Company’s Shareholder-Unfriendly Actions Intends to Vote for Director Candidates Nominated by Sham Gad at the 2025 Annual Meeting of Shareholders MISSION VIEJO, CA / ACCESS Newswire / May 29, 2025 / Kevin Ting, who beneficially owns approximately 11.7% of the outstanding shares of common stock of Paragon Technologies, Inc. (OTC

Gyre Therapeutics Announces Closing of its Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

(NASDAQ:GYRE), SAN DIEGO, May 29, 2025 (GLOBE NEWSWIRE) — Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems affected by chronic disease, today announced that it closed its previously announced underwritten public offering of 2,555,555 shares of its common stock, including the full exercise by the

Scroll to Top